Organic Chemistry TRIZ Cases

Specific heterocyclic and heteroaryl groups modify HIV protease inhibitors to reduce hepatic metabolism and support less frequent dosing.

Polymorphism can disrupt drug stability, solubility, and bioavailability; XRPD, DSC, TGA, and controlled preparation conditions help define reproducible forms.

Low electron mobility and poor thermal stability limit organic devices; this compound combines a nitrogen heterocycle with an adamantane-fluorene group.

Specific bicarbazole cores and added carbazole groups optimize hole transport and emission for greater OLED efficiency and longer device life.

Ester, thioester, and hydrazide moieties help SMO antagonists degrade in blood, limiting systemic exposure while supporting topical Hedgehog-pathway treatment.

Water-soluble multifunctional crosslinkers replace VOC-based solvents in UV-cured lubricious coatings for plastic medical devices.

The negative-type resin uses functionalized binder chemistry to improve pigment compatibility, pattern straightness, and OLED luminance without a polarizing plate.

Aromatic nitrogen insertion and substitution tuning address poor solubility and high lipophilicity while preserving potent, selective GPR52 activation.

Small-molecule NPRA agonists address the short half-lives of ANP and BNP by sustaining receptor activation for cardiometabolic disease treatment.

Liquid nicotine absorbs into porous cellulosic fibers, stabilizing it for molded oral products with adjustable release rates.

Repeated apheresis offers only temporary Lp(a) reduction; pyrrolidine compounds provide a pharmaceutical approach to lowering this cardiovascular risk factor.

Compounds targeting KIF18A ATPase activity induce mitotic arrest and apoptosis, addressing uncontrolled proliferation in cancer cells.

Thermally flowable organic films fill and planarize complex substrates while balancing fine-pattern resolution, etch resistance, and adhesion.

Limited fluoropolymer varieties and specialized reactors are addressed with a PEG-grafted semi-fluorinated copolymer that forms micelles at low concentration.

YAP1/TAZ-TEAD inhibition by these acrylamide-substituted indane compounds offers a small-molecule route to address cancer drug resistance.

Hydroxylamine buildup limits aromatic nitro reduction; nitroreductase and a disproportionation agent drive over 90% amine yield at ambient conditions.

Selective mutant IDH inhibition blocks α-KG-to-D-2-HG conversion while preserving normal TCA cycle function.

Controlled E/Z macrocycle ratios strengthen powdery, creamy musk notes while reducing metallic character in perfuming compositions.

Oxidizing HMF with molecular oxygen and a reusable ruthenium catalyst enables high-yield FDCA production, followed by nanofiltration for purity.

Specific polycyclic compounds in transport and emission layers improve charge and heat resistance for longer element service life.

Apple juice catalyzes N-substituted pyrrole formation from amines and hexadione under mild aqueous conditions, avoiding hazardous reagents and organic solvents.

Limited options for KRAS-mutated cancers motivate naphthyridine compounds that inhibit KRAS activity.

Specific heteroaryl host structures address the OLED trade-off between high driving voltage, luminous efficiency, and lifespan.

FL118 complexes combine cyclodextrins, human proteins or fragments, and salts to degrade DDX5, UbE2T, and USP2a linked to drug resistance.

A hypervalent iodine and carboxylic acid resist supports high-sensitivity EUV micropatterning with improved resolution and lower LWR.

Iodine-enhanced EUV absorption and localized acid generation help the resist balance sensitivity with LWR, CDU, solvent solubility, and etch resistance.

CRBN-recruiting PROTACs link NVS-PAK1-1 to targeted ubiquitination, addressing weak PAK1 selectivity, stability, and micromolar potency.

An indolocarbazole compound helps photoelectric imaging devices generate and move charge for higher sensitivity and resolution.

A Formula (I) electron-transport compound tunes LUMO level and dipole moment to balance OLED lifetime, efficiency, and driving voltage.

Conventional deuteration can demand costly high-temperature, high-pressure synthesis; this approach uses a transition-metal catalyst and heavy water under mild conditions.

Recovering Saflufenacil from mother liquor uses pH-driven salt formation, aqueous extraction, and organic back-extraction to limit degradation.

Small molecular changes make aroma prediction difficult; norbornane derivatives provide toasted coconut and nutty notes for fragrance and flavor products.

Small-molecule inhibitors target IL-4 signaling to reduce inflammation across autoimmune, allergic, arthritis, and cancer-related conditions.

Replacing DMSO with an alcoholic solvent and phase-transfer catalyst addresses thermal decomposition, waste, and low yields.

A hypervalent iodine compound exchanges ligands with a carboxy polymer, improving resist sensitivity and resolution for precise EUV micropatterns.

A magnesium-based Grignard route forms δ-tocotrienol at elevated temperatures, avoiding toxic reagents and difficult cryogenic processing.

The case targets KRAS-mutant signaling with SOS1 inhibitors designed for oral absorption, metabolic stability, and low CYP inhibition.

Photosensitized polymer blends support precise OTFT patterning while protecting organic semiconductor layers from oxygen plasma and aggressive solvents.

Defined ionizable lipid structures help nanoparticles encapsulate mRNA and target tissues while reducing multi-lipid formulation complexity.

Replacing carbon monoxide and hydrazine with metal-catalyzed conditions simplifies intermediate synthesis for safer industrial scale-up.

Fluorinated building blocks address limited selectivity and scale-up in 1-position N-substitution while enabling 5-position trifluoromethyl pyridones.

Carboxyl anions and tertiary sulfonium groups keep the polymer water-soluble while stabilizing proteins at low concentration and scavenging reactive oxygen species.

Heteroaryl aminopropanol compounds inhibit LTA4H, elevate lipoxin A4 biosynthesis, and promote resolution of chronic inflammation.

High-pressure hydrogenation and extra purification affect product quality; this route combines batch and fixed-bed hydrogenation for selective diamine synthesis.

YAP-TEAD interaction inhibition uses formula (Ia) compounds to address Hippo pathway dysregulation in cancer and chronic pain.

A PROTAC molecule combines selective IRAK4 kinase inhibition with ubiquitin-proteasome degradation to address resistance and limited activity.

A compound emitting layer pairs a first material with a fluorescent dopant to address efficiency roll-off at high current density.

Specific nitrile compounds help keep acrylonitrile stable in iron or iron-alloy containers, limiting polymerization during storage.

Quinazoline derivatives use a halogen-containing reactive group to form covalent cysteine bonds, enabling durable tyrosine kinase inhibition.

An organic blue-absorbing film selectively captures blue light in small pixels, improving sensitivity and reducing inter-pixel crosstalk.